ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,690 | -14.4% | 8,104 | +34.2% | 0.00% | 0.0% |
Q2 2023 | $30,004 | +0.6% | 6,037 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $29,823 | -28.0% | 6,037 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $41,414 | -36.3% | 6,037 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $65,000 | -4.4% | 6,037 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $68,000 | +38.8% | 6,037 | +13.2% | 0.00% | +50.0% |
Q1 2022 | $49,000 | -38.8% | 5,332 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $80,000 | -41.6% | 5,332 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $137,000 | -1.4% | 5,332 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $139,000 | -14.2% | 5,332 | +16.1% | 0.01% | -16.7% |
Q1 2021 | $162,000 | +39.7% | 4,594 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $116,000 | -32.9% | 4,594 | 0.0% | 0.01% | -37.5% |
Q3 2020 | $173,000 | -5.5% | 4,594 | +7.2% | 0.01% | -11.1% |
Q2 2020 | $183,000 | +181.5% | 4,285 | +27.9% | 0.01% | +125.0% |
Q1 2020 | $65,000 | -25.3% | 3,351 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $87,000 | -4.4% | 3,351 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $91,000 | +1.1% | 3,351 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $90,000 | +76.5% | 3,351 | +90.1% | 0.00% | +100.0% |
Q1 2019 | $51,000 | +8.5% | 1,763 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $47,000 | – | 1,763 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |